Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP-TN (Loxoprofen/Methocarbamol) in Muscle Strain Pain
NCT02831569Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of loxoprofen and methocarbamol in low back pain (LBP), adhesive capsulitis (AC) and Cervicobrachial syndrome (CBS), sponsored by Boehringer Ingelheim. Primary endpoint: Percentage of Patients With Drug-related Adverse Events at 3 weeks. Started Jul 2016; status: completed.
02
Drugs
loxoprofenmethocarbamol
03
Conditions
low back pain (LBP)adhesive capsulitis (AC)Cervicobrachial syndrome (CBS)
Beyond the preview
Go deeper on NCT02831569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831569.